- Home
- BIOA vs ATOM Comparison
BIOA vs ATOM Comparison
Compare BIOA & ATOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIOA
- ATOM
- Stock Information
- Founded
- BIOA 2015
- ATOM 2001
- Country
- BIOA United States
- ATOM United States
- Employees
- BIOA N/A
- ATOM N/A
- Industry
- BIOA Biotechnology: Pharmaceutical Preparations
- ATOM Semiconductors
- Sector
- BIOA Health Care
- ATOM Technology
- Exchange
- BIOA Nasdaq
- ATOM Nasdaq
- Market Cap
- BIOA 144.1M
- ATOM 121.0M
- IPO Year
- BIOA 2024
- ATOM 2016
- Fundamental
- Price
- BIOA $4.11
- ATOM $6.50
- Analyst Decision
- BIOA Hold
- ATOM Strong Buy
- Analyst Count
- BIOA 4
- ATOM 1
- Target Price
- BIOA $5.67
- ATOM $7.00
- AVG Volume (30 Days)
- BIOA 246.5K
- ATOM 394.7K
- Earning Date
- BIOA 05-06-2025
- ATOM 05-06-2025
- Dividend Yield
- BIOA N/A
- ATOM N/A
- EPS Growth
- BIOA N/A
- ATOM N/A
- EPS
- BIOA N/A
- ATOM N/A
- Revenue
- BIOA $1,451,000.00
- ATOM $121,000.00
- Revenue This Year
- BIOA N/A
- ATOM $580.00
- Revenue Next Year
- BIOA N/A
- ATOM N/A
- P/E Ratio
- BIOA N/A
- ATOM N/A
- Revenue Growth
- BIOA N/A
- ATOM N/A
- 52 Week Low
- BIOA $2.88
- ATOM $2.31
- 52 Week High
- BIOA $26.62
- ATOM $17.55
- Technical
- Relative Strength Index (RSI)
- BIOA N/A
- ATOM 72.49
- Support Level
- BIOA N/A
- ATOM $4.58
- Resistance Level
- BIOA N/A
- ATOM $5.15
- Average True Range (ATR)
- BIOA 0.00
- ATOM 0.48
- MACD
- BIOA 0.00
- ATOM 0.30
- Stochastic Oscillator
- BIOA 0.00
- ATOM 85.71
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.
About ATOM Atomera Incorporated
Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the majority of widely used transistor types in the semiconductor industry. The mears silicon technology of the company can be used for applications like Analog, DRAM, logic and processors, and SRAM.